In 2018, Zang et al. observed that GJ-4 improves cognitive ability partly by downregulating AChE levels and upregulating ACh levels in the cortex and hippocampus at 10 days after Aβ25–35-induced AD [56]. Here, ACHE is linked to Alzheimer disease.